Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALDESLEUKIN for Bladder cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where ALDESLEUKIN was used for Bladder cancer.

Most Reported Side Effects for ALDESLEUKIN

Side Effect Reports % Deaths Hosp.
Pyrexia 112 13.5% 10 34
Off label use 105 12.6% 4 27
Pain 76 9.2% 1 16
Hypotension 62 7.5% 18 37
Drug ineffective 53 6.4% 3 19
Thrombocytopenia 52 6.3% 14 29
Hypoxia 47 5.7% 17 32
Fatigue 46 5.5% 7 16
Chills 45 5.4% 6 20
Acute kidney injury 41 4.9% 12 36
Febrile neutropenia 41 4.9% 4 15
Cardiotoxicity 40 4.8% 2 3
Nausea 38 4.6% 9 15
Pancytopenia 38 4.6% 6 29
Anaemia 35 4.2% 3 14

Other Indications for ALDESLEUKIN

Neuroblastoma (146) Metastatic malignant melanoma (137) Product used for unknown indication (115) Malignant melanoma (37) Neoplasm (23) Acute myeloid leukaemia (21) Graft versus host disease (21) Non-small cell lung cancer (20) Renal cell carcinoma (18) Metastatic renal cell carcinoma (17)

Other Drugs Used for Bladder cancer

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279) PEMBROLIZUMAB (869) GEMCITABINE (841) CISPLATIN (780) ENFORTUMAB VEDOTIN-EJFV (530) NIVOLUMAB (512) ATEZOLIZUMAB (487) CARBOPLATIN (332) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326) GEMCITABINE\GEMCITABINE (240)

Related Pages

ALDESLEUKIN Full Profile All Bladder cancer Drugs ALDESLEUKIN Demographics ALDESLEUKIN Timeline